Self-monitoring blood glucose devices Market

Published on 2025-11-06
Report Code: 1486
170-350 pages

Self-monitoring blood glucose devices Market

Self-monitoring blood glucose devices: By Product (Test Strips, Lancets, Blood Glucose Meters), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, Diagnostic Centers), And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031

Buy Now

Add to cart

Table Of Content

1 Executive Summary
2 Global Self-monitoring blood glucose devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 Average Pricing Analysis
5 Macro-Economic Indicators
6 Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8 Recent Development, Policies & Regulatory Landscape
9 Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 Global Self-monitoring blood glucose devices Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 Global Self-monitoring blood glucose devices Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 Global Self-monitoring blood glucose devices Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Test Strips, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Lancets, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Blood Glucose Meters, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Type 1 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Type 2 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Gestational Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End User: Market Share (2020-2031F)
12.4.1. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Home Settings, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Diagnostic Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 Company Profile
13.1. F. Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Dexcom Inc
13.3. Bayer AG
13.4. Medtronic Public Limited
13.5. Abbott Laboratories
13.6. B. Braun Melsungen AG
13.7. Arkray, Inc.
13.8. Trividia Health Inc.
13.9. Bionime Corporation
13.10. Life Scan Inc.
13.11. Other Prominent Players
14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.